Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction
Su Yeong Park, Min Gyu Kong, Inki Moon, Hyun Woo Park, Hyung-Oh Choi, Hye Sun Seo, Yoon Haeng Cho, Nae-Hee Lee, Kwan Yong Lee, Ho-Jun Jang, Je Sang Kim, Ik Jun Choi, Jon Suh
Korean J Intern Med. 2023;38(5):692-703. Published online 2023 Aug 31 DOI: https://doi.org/10.3904/kjim.2023.065
Citations to this article as recorded by 
Exploring hypertension-linked diseases: a comprehensive review of innovative drug combinations with enhanced therapeutic potential
Bhavesh Thakkar, Hetvi Dadhaniya, Kiran Dudhat
Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(6): 6643. CrossRef
Patterns of use and dose optimization of renin-angiotensin system modulators among chronic heart failure patients with reduced ejection fraction in resource-limited settings: a multicenter cohort study
Sisay Sitotaw Anberbr, Samuel Berihun Dagnew, Getachew Yitayew Tarekegn, Fisseha Nigussie Dagnew, Zufan Alamrie Asmare, Teklie Mengie Ayele, Eskedar Dires Gebremeskel, Samuel Agegnew Wondm, Tilaye Arega Moges
Therapeutic Advances in Chronic Disease.2025;[Epub] CrossRef